Jiaying Cheng
Guangzhou, 510515, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.
Journal: BMC cancer
Published: January 02, 2026
ALDH3A2-mediated fatty acid synthesis induces ferroptosis and AML drug resistance.
Journal: iScience
Published: July 25, 2025
The clinical utility of metagenomic next-generation sequencing in the management of fever in patients with hematological disorders.
Journal: Nagoya journal of medical science
Published: June 17, 2025
Clinical efficacy and safety of venetoclax combined with hypomethylating agents in relapsed high-risk acute myeloid leukemia patients after allogeneic hematopoietic stem cell transplantation.
Journal: Frontiers in medicine
Published: June 03, 2025
Dynamics of measurable residual disease for risk stratification and guiding allogeneic transplant in acute myeloid leukaemia patients with myelodysplasia-related mutations in first remission.
Journal: British journal of haematology
Published: August 08, 2024
Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD+ acute myeloid leukemia by inhibiting β-catenin activity via the PP2A-GSK3β axis.
Journal: Cell communication and signaling : CCS
Published: May 01, 2024
Inhibition of EZH2 by chidamide exerts antileukemia activity and increases chemosensitivity through Smo/Gli-1 pathway in acute myeloid leukemia.
Journal: Journal of translational medicine
Published: October 04, 2020
Impact of FLT3-ITD allele ratio and ITD length on therapeutic outcome in cytogenetically normal AML patients without NPM1 mutation.
Journal: Bone marrow transplantation
Published: March 27, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026